January 2026
Address New GLP-1 Agonist Side Effect Concerns
Your team will need to be prepared to answer questions about whether recent side effect claims about GLP-1 agonists are true. Our articles analyze claims about whether GLP-1s are linked with hair loss, erectile dysfunction, or suicide. We also sort out whether GLP-1 agonists should be stopped prior to surgery due to aspiration risk. Readers can also listen to or watch our latest Rumor vs Truth podcast, where our editors dive deeper into the evidence about GLP-1 side effect claims.
Read More:
Community Pharmacies: Point Out Caveats With Direct-to-Consumer Meds
Your staff will need to understand and explain the nuances of direct-to-consumer (DTC) Rx programs. Our articles point out pros and cons, including that DTC programs may not always lead to big savings. We also discuss other considerations with DTC programs such as the need for increased vigilance when updating patient med lists. Readers can use our Guide for Helping Patients Afford Their Meds to help patients use cost-effective meds right off the bat instead of jumping to a DTC Rx option.
Read More:Hospitals: Have a Plan When It Comes to Hazardous Med Spills
Your team can help prevent dangerous exposures from hazardous drug spills. Our articles discuss a practical approach to remember the steps to address a spill and gives best practices for spill kit contents. We also review what to do if a team member comes in direct contact with a hazardous med, as well as ways to prevent spills. Readers can refer to our Handling Hazardous Meds resource for more on cleaning requirements, assessment of risk, and personal protective equipment.
Read More:Patients using GLP-1 receptor agonists (GLP-1 RA), such as semaglutide or tirzepatide, for weight loss may experience undesired effects including loss of muscle mass and nutrient deficiencies. Our NatMed article provides practical strategies to help patients maintain muscle mass while using a GLP-1 RA. For instance, we suggest boosting protein intake, such as up to 1.5 g/kg/day for physically active adults on a GLP-1 RA, and including regular strength training as part of the physical activity regimen. We also provide guidance about dietary strategies and the role of supplements to avoid nutrient deficiencies while on a GLP-1 RA.
Patients using GLP-1 receptor agonists (GLP-1 RA), such as semaglutide or tirzepatide, for weight loss may experience undesired effects including loss of muscle mass and nutrient deficiencies. Our NatMed article provides practical strategies to help patients maintain muscle mass while using a GLP-1 RA. For instance, we suggest boosting protein intake, such as up to 1.5 g/kg/day for physically active adults on a GLP-1 RA, and including regular strength training as part of the physical activity regimen. We also provide guidance about dietary strategies and the role of supplements to avoid nutrient deficiencies while on a GLP-1 RA.
Listen to this month’s podcast episode, Smoking and Vaping Cessation, as our expert panel discusses evidence-based approaches to help patients quit smoking, vaping, and using other nicotine products. You’ll gain practical insights on medication selection, combination strategies, and tailored approaches for helping patients break free from nicotine addiction.
All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to or watch the latest episode, GLP-1 Side Effects, as hosts Don and Steve dig into the evidence behind the most talked-about risks of GLP-1 agonists, separating clinical truth from rumors and headlines.
We’re excited to share that Rumor vs Truth podcast episodes now offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to our latest episode, Preventing Respiratory Syncytial Virus (RSV): Immunization Updates, as Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children.
We’re excited to share that Clinical Capsules podcast episodes now offer CE credit to subscribers for 2 years after their release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Dates: January 3 and 15, 2025
In this month's live webinar, Antimicrobial Stewardship: Putting Principles into Practice, you'll hear our panelists review important concepts to help decrease antibiotic resistance. And you'll listen as our panelists share their practical approaches on how to limit unnecessary antimicrobial use.
Submit your questions here for a chance to have them answered during the webinar.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
Upcoming 2026 Live Webinars
Check out our upcoming Pharmacy Essential live CE webinars. Topics include:
January
*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.
GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Pharmacotherapy of Acne
Use our updated resource as a quick reference to available products, formulations, and estimated cost.
Stepwise Treatment of Asthma (12 Years and Older) and Stepwise Treatment of Asthma (Under 12 Years of Age)
Potentially Harmful Drugs in Children
Refer to our updated chart for a listing of potentially unsafe or inappropriate drugs and excipients in pediatric patients along with alternatives.
USP <800> Isn’t Just for Pharmacies—Here’s Who’s Still at Risk
By Adam West, Course and Curriculum Manager at CriticalPoint
Veterinary oncology clinics face unique hazardous drug safety challenges. This month, The Compounding Chronicles reveal how gaps in awareness, training, and containment can impact staff and pet safety and why USP <800> matters beyond traditional pharmacy settings.
USP <800> Isn’t Just for Pharmacies—Here’s Who’s Still at Risk
By Adam West, Course and Curriculum Manager at CriticalPoint
Veterinary oncology clinics face unique hazardous drug safety challenges. This month, The Compounding Chronicles reveal how gaps in awareness, training, and containment can impact staff and pet safety and why USP <800> matters beyond traditional pharmacy settings.
As the new year begins, now is the perfect time to shore up your compounding practices for 2026, before gaps become risks. Evolving USP <795>, <797>, and <800> standards demand precision, yet many organizations still face fragmented training, inconsistent SOPs, and limited visibility into staff readiness. Without a unified approach, it becomes increasingly difficult to maintain consistency, reduce risk, and stay inspection-ready across every location and shift.
TRC Healthcare's Compounding Compliance Suite simplifies the process and helps you:
Whether you're onboarding new staff or reinforcing best practices, this suite gives you the structure and support to build a confident, compliant compounding program, without the administrative burden.
Join us on January 28 at 3:00 p.m. ET for a webinar introducing TRC Healthcare’s new Pharmacy Workforce Solutions—a unified, role-based approach to developing your entire pharmacy team to achieve your specific business goals.
Can’t attend live? Register anyway and we’ll send you the recording.